BVS vs SO · rev $573.3M vs P/E 22, rev $29.55B
Bioventus Inc (BVS) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
BVS currently screens at market cap $495.1M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the BVS and SO stock pages for the full models.
Not investment advice.